Filter
Sort
eHIV Review Special Edition, Issue 1
eHIV Review Special Edition, Issue 1

Marginalized individuals at risk for or living with HIV — the formerly incarcerated, immigrants, people with unstable housing, residents of rura...

Expired: 01.23.2025
Issue 12
Issue 12

In this issue: In this video follow-up interview to last issue’s Stigma and HIV, David Pantalone, PhD, a professor from the University of Massac...

Expired: 12.21.2025
Issue 11
Issue 11

Stigma and HIV. It’s something both clinicians and the patients they treat have been hearing a lot more frequently.In this issue of eHIV Review,...

Expired: 12.18.2025
Issue 10
Issue 10

A wealth of evidence confirms that adolescents and young adults (AYA) are indeed a priority population whose needs must be addressed for the US Ending...

Expired: 11.06.2025
Issue 9
Issue 9

Although adolescents and young adults (AYA; ages 13 to 24) account for more than 20% of all new HIV infections, they remain underrecognized as a prior...

Expired: 08.23.2025
Issue 8
Issue 8

Why do cisgender and transgender women, and particularly women of color, account for such a disproportionate percentage of HIV infections in the US? W...

Expired: 08.02.2025
Issue 7
Issue 7

Are cis women and trans women receiving appropriate and effective HIV testing, prevention, and treatment? Do women of color have higher rates of infec...

Expired: 06.25.2025
Issue 6
Issue 6

Non-nucleoside reverse transcriptase inhibitors (NNRTIs). Rilpivirine, in combination with cabotegravir, provides a long-acting injectable option for...

Expired: 05.30.2025
Issue 5
Issue 5

When is it appropriate to include an NNRTI (non-nucleoside reverse transcriptase inhibitor) like rilpivirine or doravirine in an ART regimen? What do...

Expired: 05.16.2025
Issue 4
Issue 4

Patients with HIV that cannot be treated with currently available therapies because of multiple resistance mutations. ART with cumbersome dosing sched...

Expired: 04.26.2025
Issue 3
Issue 3

Results from recent studies of two first-in-class antiretrovirals, as well as preliminary results of broadly neutralizing antibody therapies, may expa...

Expired: 03.28.2025
Issue 2
Issue 2

Stigma. What is it, and where does it come from? How do LGBTQ+ individuals, particularly those with HIV, experience it? How does stigma affect their m...

Expired: 01.11.2025
Issue 1
Issue 1

Among the LGBTQ+ population, why is HIV virologic suppression lower in the transgender and gender-diverse (trans) populations? Why are trans women 66...

Expired: 01.09.2025
Issue 12
Issue 12

Treatment-experienced patients with RAMs — resistance-associated mutations — remain a difficult management challenge. Every case of HIV dr...

Expired: 10.10.2024
Issue 11
Issue 11

For clinicians seeking to provide the most effective HIV management, choosing ART for treatment-experienced patients with resistance-associated mutati...

Expired: 09.26.2024
Issue 10
Issue 10

Most people living with HIV gain weight when initiating ART. For some, the weight gain signifies a “return to health”; for others, the add...

Expired: 09.06.2024